Celanese Corporation Total Liabilities
Celanese Corporation total liabilities. Based on the latest financial reports, Celanese Corporation (CE) has total liabilities worth $16.82 Billion USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Celanese Corporation liquidity resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Celanese Corporation (2001–2025)
Total liabilities of Celanese Corporation from 2001 to 2025. This chart illustrates how Celanese Corporation's total liabilities have evolved over time, based on quarterly financial data. Explore CE long-term investments to assets to see how much of total assets are deployed in long-term investments.
Celanese Corporation Competitors by Total Liabilities
The table below lists competitors of Celanese Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bumrungrad Hospital PCL
BK:BH
|
Thailand | ฿6.06 Billion |
|
Eastern Bankshares Inc
NASDAQ:EBC
|
USA | $26.25 Billion |
|
E-L Financial Corp Ltd
TO:ELF
|
Canada | CA$19.14 Billion |
|
Charoen Pokphand Foods Public Company Limited
BK:CPF
|
Thailand | ฿618.83 Billion |
|
Crocs Inc
NASDAQ:CROX
|
USA | $2.92 Billion |
|
Montage Gold Corp.
TO:MAU
|
Canada | CA$847.81 Million |
|
Lifan Industry Group Co Ltd
SHG:601777
|
China | CN¥12.84 Billion |
|
SIG Combibloc Group AG
SW:SIGN
|
Switzerland | CHF4.41 Billion |
Liability Composition Analysis (2001–2025)
This chart breaks down Celanese Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Celanese Corporation asset portfolio.
Liquidity & Leverage Metrics
Celanese Corporation Total Liabilities Ratios Explained
Celanese Corporation total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.23 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 4.04 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.79 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Celanese Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Celanese Corporation (2001–2025)
The table below shows the annual total liabilities of Celanese Corporation from 2001 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $17.22 Billion | -0.14% |
| 2024-12-31 | $17.25 Billion | -9.44% |
| 2023-12-31 | $19.05 Billion | -5.56% |
| 2022-12-31 | $20.17 Billion | +171.13% |
| 2021-12-31 | $7.44 Billion | +6.05% |
| 2020-12-31 | $7.01 Billion | +6.63% |
| 2019-12-31 | $6.58 Billion | +10.85% |
| 2018-12-31 | $5.93 Billion | -4.89% |
| 2017-12-31 | $6.24 Billion | +16.92% |
| 2016-12-31 | $5.34 Billion | -7.31% |
| 2015-12-31 | $5.76 Billion | +0.30% |
| 2014-12-31 | $5.74 Billion | -9.16% |
| 2013-12-31 | $6.32 Billion | -14.93% |
| 2012-12-31 | $7.43 Billion | +3.50% |
| 2011-12-31 | $7.18 Billion | -2.45% |
| 2010-12-31 | $7.36 Billion | -5.99% |
| 2009-12-31 | $7.83 Billion | +12.09% |
| 2008-12-31 | $6.98 Billion | -0.13% |
| 2007-12-31 | $6.99 Billion | -0.61% |
| 2006-12-31 | $7.03 Billion | -1.57% |
| 2005-12-31 | $7.15 Billion | +2.03% |
| 2004-12-31 | $7.00 Billion | +66.21% |
| 2003-12-31 | $4.21 Billion | -2.48% |
| 2002-12-31 | $4.32 Billion | +1.01% |
| 2001-12-31 | $4.28 Billion | -- |
About Celanese Corporation
Celanese Corporation produces and sells engineered polymers worldwide. It operates through Engineered Materials and Acetyl Chain segments. The company offers ethylene acrylic elastomers, ethylene vinyl acetate pharmaceutical grade copolymers, liquid crystal polymers, long-fiber reinforced thermoplastics, nylon and polypropylene compounds and formulations, polyoxymethylene, ultra-high molecular we… Read more